These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17359393)

  • 1. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Clin Exp Allergy; 2007 Mar; 37(3):434-40. PubMed ID: 17359393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of a depigmented, polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthma.
    Pfaar O; Klimek L; Sager A; Bräutigam M
    Am J Rhinol Allergy; 2010; 24(3):220-5. PubMed ID: 20167138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of immunotherapy with glutaraldehyde modified allergen extracts in children and adults.
    Guzmán-Fulgencio M; Caballero R; Lara B; Mena M; Tejera M; Sastre A; Subiza JL; Fernández-Caldas E; Casanovas M
    Allergol Immunopathol (Madr); 2017; 45(2):198-207. PubMed ID: 27939406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
    Alvarez-Cuesta E; Aragoneses-Gilsanz E; Martín-Garcia C; Berges-Gimeno P; Gonzalez-Mancebo E; Cuesta-Herranz J
    Clin Exp Allergy; 2005 May; 35(5):572-8. PubMed ID: 15898977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C; Monzón S; Venturini M; Lezaun A
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
    Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
    Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy.
    Schiappoli M; Ridolo E; Senna G; Alesina R; Antonicelli L; Asero R; Costantino MT; Longo R; Musarra A; Nettis E; Crivellaro M; Savi E; Massolo A; Passalacqua G
    Clin Exp Allergy; 2009 Oct; 39(10):1569-74. PubMed ID: 19486027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus.
    Casanovas M; Fernández-Caldas E; Alamar R; Basomba A
    Int Arch Allergy Immunol; 2005 Jul; 137(3):211-8. PubMed ID: 15956789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind study of tolerability and antibody production of unmodified and chemically modified allergen vaccines of Phleum pratense.
    Casanovas M; Sastre J; Fernández-Nieto M; Lluch M; Carnés J; Fernández-Caldas E
    Clin Exp Allergy; 2005 Oct; 35(10):1377-83. PubMed ID: 16238799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years.
    Fiocchi A; Pajno G; La Grutta S; Pezzuto F; Incorvaia C; Sensi L; Marcucci F; Frati F
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):254-8. PubMed ID: 16200816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen.
    Asero R; Monsalve R; Barber D
    Clin Exp Allergy; 2008 Jun; 38(6):1033-7. PubMed ID: 18489029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
    J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.